RxDoctor Payments Data

Marc Silverstein, MD

Dermatology · Sacramento, CANPI 1104869155

Payments from drug & device makers

$3,053in general payments, 2019–2025

Across 29 payments — averaging $105.28 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$698
  • Lilly USA, LLC$341
  • Regeneron Healthcare Solutions, Inc.$249
  • Janssen Scientific Affairs, LLC$248
  • UCB, Inc.$193
  • Pfizer$180
  • plus $1K from 9 others

What the payments were for

  • Food & beverage$3,053100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$3,053 in reported general payments places this provider in the 55th percentile of 1,875 dermatology providers in California.

See all dermatology providers in California

Medicare billing

Part B allowed, 2024
$191,438
Medicare patients
523
Services billed
2,948

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Dupixent PenDupilumab66$267,270
Taltz AutoinjectorIxekizumab12$81,404
Dupixent SyringeDupilumab15$60,305
Clobetasol Propionate57$4,758
Fluorouracil21$1,049
Fluocinonide19$545
Doxycycline Hyclate19$509
Triamcinolone Acetonide42$287
Gabapentin15$281
Mupirocin16$121
Hydrocortisone12$64
Prednisone12$58

Paid to pharmacies, not to this prescriber.

Other dermatology in Sacramento

See the full list for California

Where these figures come from

Is this you, or does something look wrong? →